Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/32696| Title: | Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study) | Authors: | Hartung, H-P Comi, G. Arnold, D. L. Boyko, A. N. Havrdova, E. K. Inshasi, J. S. McCombe, P. Nakamura, K. Oreja-Guevara, C. Pelletier, D. Pozzilli, C. Selmaj, K. W. Scott, T. F. Chung, L. Daizadeh, N. Afsar, S. VAN WIJMEERSCH, Bart |
Issue Date: | 2020 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 26 (9) , p. NP60 -NP61 | Document URI: | http://hdl.handle.net/1942/32696 | ISI #: | WOS:000556862300071 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.